tirzepatide and cancer Tirzepatide—Friend or Foe in Diabetic Patients? GLP-1s and Cancer: Emerging Research

When to lean on peer support for bipolar disorder, and when you should look elsewhere

It offers a compre Book Now Dried blood spot testing that only requires a finger stick and few drops of blood on a card can be easily and safely sent to the lab for analysis

Microbiome disruption can trigger vaginal changes and irritation

These variants do not predict exact semaglutide response or lipo C efficacy, but they can support a more informed discussion with your provider about baseline metabolic tendencies and whether your timing protocol should account for individual pathway activity

(Zepbound/Mounjaro) Tirzepatide is a prescription medication that effectively promotes weight loss

Abstract Introduction Once-weekly semaglutide 1 mg is a novel glucagon-like peptide 1 receptor agonist (GLP-1 RA) that, in the SUSTAIN clinical trials, has demonstrated greater reductions in glycated haemoglobin (HbA1c) and body weight than the other GLP-1 RAs exenatide extended-release (ER) 2 mg, dulaglutide 1.5 mg and liraglutide 1.2 mg